Modeling microRNA-mRNA interactions using PLS regression in human colon cancer

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Li, Xiaohong ^a,b   Gill, Ryan ^a   Cooper, Nigel Gf ^b   Yoo, Jae Keun ^c   Datta, Susmita ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ALGORITHM; ARTICLE; BIOINFORMATICS; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MOLECULAR MODEL; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; BIOLOGICAL MODEL; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; COLON TUMOR; GENETICS; LABORATORY DIAGNOSIS; METABOLISM; REGRESSION ANALYSIS;

ALGORITHMS; BIOLOGICAL PROCESSES; COLONIC NEOPLASMS; DOWN-REGULATION; FALSE POSITIVE REACTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; LEAST-SQUARES ANALYSIS; MICRORNAS; MODELS, GENETIC; RNA, MESSENGER; UP-REGULATION;

EID: 79955983466     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-44     Document Type: Article

References (46)

1. Colon cancer: Current and emerging trends in detection and treatment. M Stokes, Cancer and modern sciences published by Rosen Publishing group, Inc 1 2006
2. http://en.wikipedia.org/wiki/Colorectal-cancer
3. Cancer statistics. RT Greenlee MB Hill-Harmon T Murray M Thun, CA Cancer J Clin 2001 51 15 36 10.3322/canjclin.51.1.15 11577478
4. Global cancer statistics. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2002 55 74 108
5. Cancer Statistics. AR Jemal E Siegel E Ward T Murray T Xu MJ Thun, Cancer J Clin 2007 57 43 66 10.3322/canjclin.57.1.43
6. Adjuvant therapy in colon cancer-what, when and how? I Chau AH Wylie, Ann Oncol 2006 17 1347 1359 10.1093/annonc/mdl029 16524974 (Pubitemid 44400373)
7. MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. WCS Cho, Inter J Biochem Cell Biolo 2009 online
8. Repression of protein synthesis by miRNAs: how many mechanisms? RS Pillai SN Bhattacharyya W Filipowicz, Trends Cell Biolo 2007 17 118 126 10.1016/j.tcb.2006.12.007 (Pubitemid 46357525)
9. A computational view of miRNAs and their targets. JR Brown P Sanseau, Drug Discovery Today 2005 10 595 601 10.1016/S1359-6446(05)03399-4 15837603 (Pubitemid 40544801)
10. The microRNA.org resource: targets and expression. D Betel M Wilson AK Gabow DS Marks C Sander, Nucleic Acids Research 2008 36 149 153
11. Lost in translation: an assessment and perspective for computational microRNA target identification. P Alexiou M Maragkakis GL Papadopoulos M Reczko AG Hatzigeorgiou, Bioinformatics 2009 25 3049 3055 10.1093/bioinformatics/btp565 19789267
12. miR-15 and miR-16 induce apoptosis by targeting BCL2. A Cimmino GA Calin M Fabbri MV Lorio M Ferracin M Shimizu, Proc Natl Acad Sci USA 2005 102 13944 13949 10.1073/pnas.0506654102 16166262 (Pubitemid 41377683)
13. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. AM Roccaro BA Sacco B Thompson X Leleu AK Azab F Azab, Blood 2009 113 6669 6680 10.1182/blood-2009-01-198408 19401561
14. RAS is regulated by the let-7 microRNA family. SM Johnson H Grosshans J Shingara M Byrom R Jarvis A Cheng, Cell 2005 120 635 647 10.1016/j.cell.2005.01. 014 15766527 (Pubitemid 40343076)
15. Frequent overexpression of HMGA1 and 2 in gastroentero pancreatic neuroendocrine tumors and its relationship to let-7 downrgulation. MM Rahman ZR Qian EL Wang R Sultana E Kudo M Nakasono, Br J Cancer 2009 100 501 510 10.1038/sj.bjc.6604883 19156147
16. A microRNA expression signature of human solid tumors defines cancer gene targets. S Violinia GA Calin CG Liu S Ambs A Cimmino F Petrocca, Proc Ntl Acad Sci USA 2006 103 2257 2261 10.1073/pnas.0510565103 (Pubitemid 43271657)
17. Revealing posttranscriptional regulatory elements through network-level conservation. CS Chang O Elemento S Tavazoie, PLoS Comput Biol 2005 1 69 10.1371/journal.pcbi.0010069 16355253
18. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. R Nagel C le Sage B Diosdado M van der Waal JA Oude Vrielink A Bolijn GA Meijer R Agami, Cancer Res 2008 68 5795 5802 10.1158/0008-5472.CAN-08-0951 18632633
19. Prediction of microRNA targets. P Maziere AJ Enright, Drug Disc Today 2007 12 452 458 10.1016/j.drudis.2007.04.002 (Pubitemid 46795589)
20. MicroRNA expression profiles classify human cancers. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck A Sweet-Cordero BL Ebert RH Mak AA Ferrando JR Downing T Jacks HR Horvitz RR Golub, Nature 2005 435 834 838 10.1038/nature03702 15944708 (Pubitemid 40839735)
21. Using expression profiling data to identify human microRNA targets. JC Huang T Babak TW Corson G Chua S Khan BL Gallie TR Hughes BJ Blencowe BJ Frey QD Morris, Nature methods 2007 4 1045 1049 10.1038/nmeth1130 18026111 (Pubitemid 350201777)
22. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. X Peng Y Li KA Walters ER Rosenzweig SL Lederer LD Aicher S Proll MG Katze, BMC Genomics 2009 10 373 10.1186/1471-2164-10-373 19671175
23. Exploring relationships in gene expression: a partial least square approach. S Datta, Gene Expression 2001 9 249 55 11763996 (Pubitemid 33096396)
24. Tumor classification by partial least squares using microarray gene expression data. DV Nguyen DM Rocke, Bioinformatics 2002a 18 39 50 10.1093/bioinformatics/18.1.39 (Pubitemid 34145030)
25. Discriminant models for high-throughput proteomics mass spectrometer data. P Purohit DM Rocke, Proteomics 2003 3 1699 1703 10.1002/pmic.200300518 12973728 (Pubitemid 37129815)
26. Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO. S Datta J Le-Rademacher S Datta, Biometrics 2007 63 259 271 10.1111/j.1541-0420.2006.00660.x 17447952
27. Reconstruction of genetic association networks from microarray data: A partial least squares approach. V Pihur S Datta S Datta, Bioinformatics 2008 24 561 568 10.1093/bioinformatics/btm640 18204062 (Pubitemid 351256301)
28. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Y Benjamini Y Hochberg, Journal of the Royal Stat Society. Series B (Methodological) 1995 57 289 300
29. A let-7 microRNA-binding site polymorphism in the KRAS 3'UTR associated with reduced survival in oral cancer. BC Christensen BJ Moyer M Avissar LG Ouellet SL Plaza MD McClean CJ Marsit KT Kelsey, Carcinogenesis 2009 30 1003 1007 10.1093/carcin/bgp099 19380522
30. Low-level expression of microRNAs let-7d and miR-205 are prognositic markers of head and neck squamous cell carcinoma. G Childs M Fazzari G Kung N Kawachi M Brandwein-gensier M McLemore Q Chen RD Burk RV Smith MB Prystowsky TJ Belbin NF Schlecht, Am J Pathol 2009 174 736 745 10.2353/ajpath.2009.080731 19179615
31. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. JM Friedman G Liang CC Liu EM Wolff YC Tsai W Ye, Cancer Res 2009 69 2623 2629 10.1158/0008-5472.CAN-08-3114 19258506
32. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcom viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. S Li H Fu Y Wang Y Tie R Xing J Zhu, Heptology 2009 49 1194 1202 10.1002/hep.22757
33. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. T Ichimi H Enokida Y Okuno R Kunimoto T Chiyomaru K Kawamoto, Int J Cancer 2009 125 345 352 10.1002/ijc.24390 19378336
34. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. H Xu IY Cheung HF Guo NK Cheung, Cancer Res 2009 69 6275 6281 10.1158/0008-5472.CAN-08- 4517 19584290
35. MicroRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. B Stamatopoulos N Meuleman B Haibe-Kains P Saussoy E Van Den Neste L Michaux P Heimann P Martiat D Bron L Lagneaux, Blood 2009 113 5237 5245 10.1182/blood-2008-11-189407 19144983
36. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. F Wu S Zhu Y Ding WT Beck YY Mo, Clin Cancer Res 2009 15 1550 1557 10.1158/1078-0432. CCR-08-0820 19223510
37. MicroRNAs, ultra conserved genes and colorectal cancers. S Rossi S Kopetz R Davuluri SR Hamilton GA Calin, Inter J Biochem Cell Biolo 2009 online
38. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. M Pigazzi E Manara E Baron G Basso, Cancer Res 2009 69 2471 2478 10.1158/0008-5472.CAN-08-3404 19258499
39. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. HC Chen GH Chen YH Chen WL Liao CY Liu, Br J Cancer 2009 100 1002 1011 10.1038/sj.bjc.6604948 19293812
40. Epigenetic silencing of the intronic microRNA has-miR-342 and its host gene EVL in colorectal cancer. WM Grady RK Parkin PS Mitchell JH Lee YH Kim KD Tsuchiya MK Washington C Parskeva JK Willson AM Kaz EM Kroh A Allen BR Fritz SD Markowitz M Tewari, Oncogene 2008 27 3880 3888 10.1038/onc.2008.10 18264139 (Pubitemid 351862055)
41. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. Y Zhang M Li H Wang WE Fisher PH Lin Q Yao C Chen, World J Surg 2009 33 498 709
42. Molecular assays for the detection of microRNAs in prostate cancer. AC Siva LJ Nelson CL Fleischer M Majlessi MM Becker RL Vessella MA Reynolds, Mol Cancer 2009 8 17 19267923
43. Protein expression profile using two-dimensional gel analysis in squamous cervical cancer patients. SM Bae HJ Min GH Ding SY Kwak YL Cho KH Nam CH Park YW Kim CK Kim BD Han YJ Lee K Kim do WS Ahn, Cancer Res Treat 2006 38 2 99 107 10.4143/crt.2006.38.2.99 19771267
44. Discovery and scoring of protein interaction subnetworks discriminative of late stage of human colon cancer. RK Nibbe S Markowitz L Myeroff R Ewing MR Chance, Molecular cell proteomics 2009 8 4 827 845 10.1074/mcp.M800428-MCP200
45. Evaluation of Oxidative Stress in Colorectal Cancer Patients. D Chang F Wang YS Zhao H Zhi, Biomedical and Environmental Sciences 2008 21 4 286 289 10.1016/S0895-3988(08)60043-4 18837290
46. Multiclass cancer diagnosis using tumor gene expression signatures. S Ramaswamy P Tamayo R Rifkin S Mukherjee CH Yeang M Angelo C Ladd M Reich E Latulippe JP Mesirov T Poggio W Gerald M Loda ES Lander TR Golub, Proc Natl Acad Sci USA 2001 98 15149 15154 10.1073/pnas.211566398 11742071 (Pubitemid 34013984)